|
1
|
Lee MC, Hsu YJ, Chen MT, Kuo YW, Lin JH, Hsu YC, Huang YY, Li CM, Tsai SY, Hsia KC, Ho HH, Huang CC. Efficacy of Lactococcus lactis subsp. lactis LY-66 and Lactobacillus plantarum PL-02 in Enhancing Explosive Strength and Endurance: A Randomized, Double-Blinded Clinical Trial. Nutrients 2024; 16:1921. [PMID: 38931275 PMCID: PMC11206817 DOI: 10.3390/nu16121921] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2024] [Revised: 06/14/2024] [Accepted: 06/15/2024] [Indexed: 06/28/2024] Open
Abstract
Probiotics are posited to enhance exercise performance by influencing muscle protein synthesis, augmenting glycogen storage, and reducing inflammation. This double-blind study randomized 88 participants to receive a six-week intervention with either a placebo, Lactococcus lactis subsp. lactis LY-66, Lactobacillus plantarum PL-02, or a combination of both strains, combined with a structured exercise training program. We assessed changes in maximal oxygen consumption (VO2max), exercise performance, and gut microbiota composition before and after the intervention. Further analyses were conducted to evaluate the impact of probiotics on exercise-induced muscle damage (EIMD), muscle integrity, and inflammatory markers in the blood, 24 and 48 h post-intervention. The results demonstrated that all probiotic groups exhibited significant enhancements in exercise performance and attenuation of muscle strength decline post-exercise exhaustion (p < 0.05). Notably, PL-02 intake significantly increased muscle mass, whereas LY-66 and the combination therapy significantly reduced body fat percentage (p < 0.05). Analysis of intestinal microbiota revealed an increase in beneficial bacteria, especially a significant rise in Akkermansia muciniphila following supplementation with PL-02 and LY-66 (p < 0.05). Overall, the combination of exercise training and supplementation with PL-02, LY-66, and their combination improved muscle strength, explosiveness, and endurance performance, and had beneficial effects on body composition and gastrointestinal health, as evidenced by data obtained from non-athlete participants.
Collapse
Affiliation(s)
- Mon-Chien Lee
- Graduate Institute of Sports Science, National Taiwan Sport University, Taoyuan 333325, Taiwan; (M.-C.L.); (Y.-J.H.)
- Center for General Education, Taipei Medical University, Taipei 110301, Taiwan
| | - Yi-Ju Hsu
- Graduate Institute of Sports Science, National Taiwan Sport University, Taoyuan 333325, Taiwan; (M.-C.L.); (Y.-J.H.)
| | - Mu-Tsung Chen
- Committee on General Studies, Shih Chien University, Taipei City 104, Taiwan;
| | - Yi-Wei Kuo
- Functional R&D Department, Research and Design Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (Y.-W.K.); (J.-H.L.); (Y.-Y.H.); (C.-M.L.); (H.-H.H.)
| | - Jia-Hung Lin
- Functional R&D Department, Research and Design Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (Y.-W.K.); (J.-H.L.); (Y.-Y.H.); (C.-M.L.); (H.-H.H.)
| | - Yu-Chieh Hsu
- Research Product Department, Research and Design Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (Y.-C.H.); (S.-Y.T.); (K.-C.H.)
| | - Yen-Yu Huang
- Functional R&D Department, Research and Design Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (Y.-W.K.); (J.-H.L.); (Y.-Y.H.); (C.-M.L.); (H.-H.H.)
| | - Ching-Min Li
- Functional R&D Department, Research and Design Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (Y.-W.K.); (J.-H.L.); (Y.-Y.H.); (C.-M.L.); (H.-H.H.)
| | - Shin-Yu Tsai
- Research Product Department, Research and Design Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (Y.-C.H.); (S.-Y.T.); (K.-C.H.)
| | - Ko-Chiang Hsia
- Research Product Department, Research and Design Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (Y.-C.H.); (S.-Y.T.); (K.-C.H.)
| | - Hsieh-Hsun Ho
- Functional R&D Department, Research and Design Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (Y.-W.K.); (J.-H.L.); (Y.-Y.H.); (C.-M.L.); (H.-H.H.)
- Research Product Department, Research and Design Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (Y.-C.H.); (S.-Y.T.); (K.-C.H.)
| | - Chi-Chang Huang
- Graduate Institute of Sports Science, National Taiwan Sport University, Taoyuan 333325, Taiwan; (M.-C.L.); (Y.-J.H.)
- Tajen University, Pingtung 907101, Taiwan
| |
Collapse
|
|
2
|
Chen JF, Hsia KC, Kuo YW, Chen SH, Huang YY, Li CM, Hsu YC, Tsai SY, Ho HH. Safety Assessment and Probiotic Potential Comparison of Bifidobacterium longum subsp. infantis BLI-02, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06, and Lactobacillus paracasei ET-66. Nutrients 2023; 16:126. [PMID: 38201957 PMCID: PMC10780348 DOI: 10.3390/nu16010126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2023] [Revised: 12/25/2023] [Accepted: 12/28/2023] [Indexed: 01/12/2024] Open
Abstract
Bifidobacterium longum subsp. infantis BLI-02, Lactobacillus paracasei ET-66, Lactobacillus plantarum LPL28, and Lactobacillus acidophilus TYCA06, isolated from healthy breast milk, miso, and the healthy human gut, were assessed for safety in this study. BLI-02, LPL28, TYCA06, and ET-66 exhibited no antibiotic resistance and mutagenic activity in the Ames test at the highest dosage (5000 μg/plate). No genotoxicity was observed in micronucleus and chromosomal aberration assays in rodent spermatogonia at the maximum dosage of 10 g/kg body weight (BW). No acute and sub-chronic toxicity occurred in mice and rats at the maximum tested dosage of 10 g/kg BW and 1.5 g/kg BW, respectively. The lyophilized powder of these strains survived a low pH and high bile salt environment, adhering strongly to Caco-2 cells. Unique antimicrobial activities were noted in these strains, with BLI-02 demonstrating the best growth inhibition against Vibrio parahaemolyticus, LPL28 exhibiting the best growth inhibition against Helicobacter pylori, and ET-66 showing the best growth inhibition against Aggregatibacter actinomycetemcomitans. Based on the present study, the lyophilized powder of these four strains appears to be a safe probiotic supplement at tested dosages. It should be applicable for clinical or healthcare applications.
Collapse
Affiliation(s)
- Jui-Fen Chen
- Research Product Department, R&D Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (J.-F.C.); (K.-C.H.); (Y.-Y.H.); (C.-M.L.); (Y.-C.H.); (S.-Y.T.)
| | - Ko-Chiang Hsia
- Research Product Department, R&D Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (J.-F.C.); (K.-C.H.); (Y.-Y.H.); (C.-M.L.); (Y.-C.H.); (S.-Y.T.)
| | - Yi-Wei Kuo
- Functional Investigation Department, R&D Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan;
| | - Shu-Hui Chen
- Process Department, R&D Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan;
| | - Yen-Yu Huang
- Research Product Department, R&D Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (J.-F.C.); (K.-C.H.); (Y.-Y.H.); (C.-M.L.); (Y.-C.H.); (S.-Y.T.)
| | - Ching-Min Li
- Research Product Department, R&D Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (J.-F.C.); (K.-C.H.); (Y.-Y.H.); (C.-M.L.); (Y.-C.H.); (S.-Y.T.)
| | - Yu-Chieh Hsu
- Research Product Department, R&D Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (J.-F.C.); (K.-C.H.); (Y.-Y.H.); (C.-M.L.); (Y.-C.H.); (S.-Y.T.)
| | - Shin-Yu Tsai
- Research Product Department, R&D Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (J.-F.C.); (K.-C.H.); (Y.-Y.H.); (C.-M.L.); (Y.-C.H.); (S.-Y.T.)
| | - Hsieh-Hsun Ho
- Research Product Department, R&D Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan; (J.-F.C.); (K.-C.H.); (Y.-Y.H.); (C.-M.L.); (Y.-C.H.); (S.-Y.T.)
- Functional Investigation Department, R&D Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan;
- Process Department, R&D Center, Glac Biotech Co., Ltd., Tainan City 744, Taiwan;
| |
Collapse
|